Meyers C M, Zhang Y
University of Pennsylvania School of Medicine, Department of Medicine, Philadelphia, USA.
Kidney Int. 1999 Apr;55(4):1395-406. doi: 10.1046/j.1523-1755.1999.00394.x.
We examined the immunomodulatory effects of interferon-gamma (IFN-gamma) on renal-derived CD4+ alpha/beta + T cells, called mouse renal (MR) cells, isolated from animals with murine chronic graft-versus-host disease, a model of autoimmune glomerulonephritis. MR T cells express a Th2 cytokine profile, although IFN-gamma expression is also detected in a subset of clones that adoptively transfers renal disease to naive recipients. In view of disparate patterns of IFN-gamma expression, we evaluated the effects of exogenous IFN-gamma on nephritogenic (MR1.3) and nonnephritogenic (MR1.6) clonal activity.
These studies examined IFN-gamma-mediated effects on clonal proliferation, cytokine production, nephritogenic potential, and IFN-gamma receptor expression.
IFN-gamma mediated dose-dependent inhibition of MR1.3 and MR1.6 proliferation. This cytostatic effect was not mediated by inhibiting cytokine genes, as expression of interleukin (IL)-4, IL-10, IL-13, and IFN-gamma after IFN-gamma treatment was not markedly altered in either clone, although baseline IL-13 expression was enhanced in MR1.6. IFN-gamma markedly altered the functional phenotype of MR1.6, as pretreated recipients developed severe mononuclear cell infiltrates and tubular damage following adoptive transfer of MR1.6. Neutralizing anti-IFN-gamma antibodies did not inhibit MR1.3 nephritogenicity, but did block MR1.6-induced disease in IFN-gamma-treated mice. Although both clones constitutively expressed the IFN-gamma receptor beta chain, IFN-gamma exposure decreased its expression in MR1.3 cells, but did not markedly change its expression in MR1.6 cells.
These studies describe an unusual permissive role for IFN-gamma in modulating nephritogenic Th2 activity in vivo, which facilitates the initiation of cell-mediated autoimmune renal injury. Apparent differential effects of IFN-gamma on distinct T-cell clones may be mediated in part by alterations in cytokine receptor expression.
我们研究了干扰素-γ(IFN-γ)对从患有小鼠慢性移植物抗宿主病(一种自身免疫性肾小球肾炎模型)的动物中分离出的肾源性CD4+α/β+T细胞(称为小鼠肾(MR)细胞)的免疫调节作用。MR T细胞表达Th2细胞因子谱,尽管在将肾病过继转移给未致敏受体的一部分克隆中也检测到IFN-γ表达。鉴于IFN-γ表达模式的差异,我们评估了外源性IFN-γ对致肾炎性(MR1.3)和非致肾炎性(MR1.6)克隆活性的影响。
这些研究检测了IFN-γ介导的对克隆增殖、细胞因子产生、致肾炎潜力和IFN-γ受体表达的影响。
IFN-γ介导了对MR1.3和MR1.6增殖的剂量依赖性抑制。这种细胞生长抑制作用不是通过抑制细胞因子基因介导的,因为在IFN-γ处理后,白细胞介素(IL)-4、IL-10、IL-13和IFN-γ在两个克隆中的表达均未明显改变,尽管MR1.6中的基线IL-13表达有所增强。IFN-γ显著改变了MR1.6的功能表型,因为在过继转移MR1.6后,预处理的受体出现了严重的单核细胞浸润和肾小管损伤。中和抗IFN-γ抗体不能抑制MR1.3的致肾炎性,但能阻断IFN-γ处理小鼠中MR1.6诱导的疾病。尽管两个克隆都组成性表达IFN-γ受体β链,但IFN-γ暴露降低了MR1.3细胞中其表达,但在MR1.6细胞中未明显改变其表达。
这些研究描述了IFN-γ在体内调节致肾炎性Th2活性中的一种不同寻常的许可作用,这促进了细胞介导的自身免疫性肾损伤的起始。IFN-γ对不同T细胞克隆的明显差异作用可能部分是由细胞因子受体表达的改变介导的。